American Renal Associates Holdings, Inc. (ARA) EPS Estimated At $0.17

July 14, 2018 - By Nadine Davis

Analysts expect American Renal Associates Holdings, Inc. (NYSE:ARA) to report $0.17 EPS on August, 14.They anticipate $0.01 EPS change or 6.25 % from last quarter’s $0.16 EPS. ARA’s profit would be $5.51M giving it 22.66 P/E if the $0.17 EPS is correct. After having $0.11 EPS previously, American Renal Associates Holdings, Inc.’s analysts see 54.55 % EPS growth. The stock decreased 0.32% or $0.05 during the last trading session, reaching $15.41. About 84,283 shares traded. American Renal Associates Holdings, Inc. (NYSE:ARA) has declined 11.96% since July 14, 2017 and is downtrending. It has underperformed by 24.53% the S&P500.

American Renal Associates Holdings, Inc. operates as a dialysis services well-known provider in the United States, focuses exclusively on joint venture partnerships with physicians. The company has market cap of $499.86 million. The company, through its subsidiaries, offers kidney dialysis services to patients suffering from chronic kidney failure or end stage renal disease. It has a 105.55 P/E ratio. As of December 31, 2016, it owned and operated 214 dialysis clinics in partnership with 379 nephrologist partners treating approximately 14,000 patients in 25 states and the District of Columbia.

More news for American Renal Associates Holdings, Inc. (NYSE:ARA) were recently published by:, which released: “American Renal Associates (ARA) PT Lowered to $21 at BofA/Merrill Lynch Following UNH Agreement” on July 10, 2018.‘s article titled: “New Research: Key Drivers of Growth for Accuray, American Renal Associates, Eagle Materials, CVR Refining, LP, RR …” and published on June 28, 2018 is yet another important article.

American Renal Associates Holdings, Inc. (NYSE:ARA) Ratings Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.